Medicina
Saila
Hôpital Bichat-Claude-Bernard
París, FranciaHôpital Bichat-Claude-Bernard-ko ikertzaileekin lankidetzan egindako argitalpenak (8)
2020
-
Addition of maraviroc versus placebo to standard antiretroviral therapy for initial treatment of advanced HIV infection: A randomized trial
Annals of Internal Medicine, Vol. 172, Núm. 5, pp. 297-305
2018
-
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals
Clinical Microbiology and Infection, Vol. 24, Núm. 10, pp. 1070-1076
2015
-
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792
-
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry
Thrombosis Journal, Vol. 13, Núm. 1
2014
-
Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries
AIDS, Vol. 28, Núm. 16, pp. 2461-2473
2009
-
The expanded Global Registry of Acute Coronary Events: Baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes
American Heart Journal, Vol. 158, Núm. 2, pp. 201.e5
2008
-
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
The Lancet, Vol. 372, Núm. 9641, pp. 807-816